Title
Quantifying risks and interventions that have affected the burden of lower respiratory infections among children younger than 5 years: an analysis for the Global Burden of Disease Study 2017
Date Issued
01 January 2020
Access level
open access
Resource Type
journal article
Author(s)
Troeger C.E.
Khalil I.A.
Blacker B.F.
Biehl M.H.
Albertson S.B.
Zimsen S.R.M.
Rao P.C.
Abate D.
Admasie A.
Ahmadi A.
Ahmed M.L.C.B.
Akal C.G.
Alahdab F.
Alam N.
Alene K.A.
Alipour V.
Aljunid S.M.
Al-Raddadi R.M.
Alvis-Guzman N.
Amini S.
Anjomshoa M.
Antonio C.A.T.
Arabloo J.
Aremu O.
Atalay H.T.
Atique S.
Avokpaho E.F.G.A.
Awad S.
Awasthi A.
Badawi A.
Balakrishnan K.
Banoub J.A.M.
Barac A.
Bassat Q.
Bedi N.
Bennett D.A.
Bhattacharyya K.
Bhutta Z.A.
Bijani A.
Bills C.B.
Car J.
Carvalho F.
Castañeda-Orjuela C.A.
Causey K.
Christopher D.J.
Cohen A.J.
Dandona L.
Dandona R.
Daryani A.
Demeke F.M.
Djalalinia S.
Dubey M.
Dubljanin E.
Duken E.E.
El Sayed Zaki M.
Endries A.Y.
Fernandes E.
Fischer F.
Frostad J.
Fullman N.
Gardner W.M.
Geta B.
Ghadiri K.
Gorini G.
Goulart A.C.
Guo Y.
Hailu G.B.
Haj-Mirzaian A.
Haj-Mirzaian A.
Hamidi S.
Hassen H.Y.
Hoang C.L.
Horita N.
Hostiuc M.
Hussain Z.
Irvani S.S.N.
James S.L.
Jha R.P.
Jonas J.B.
Karch A.
Kasaeian A.
Kassa T.D.
Kassebaum N.J.
Kefale A.T.
Khader Y.S.
Khan E.A.
Khan G.
Khan M.N.
Khang Y.H.
Khoja A.T.
Kimokoti R.W.
Kisa A.
Kisa S.
Kissoon N.
Knibbs L.D.
Kochhar S.
Kosen S.
Koul P.A.
Koyanagi A.
Kuate Defo B.
Publisher(s)
Elsevier Ltd
Abstract
Background: Despite large reductions in under-5 lower respiratory infection (LRI) mortality in many locations, the pace of progress for LRIs has generally lagged behind that of other childhood infectious diseases. To better inform programmes and policies focused on preventing and treating LRIs, we assessed the contributions and patterns of risk factor attribution, intervention coverage, and sociodemographic development in 195 countries and territories by drawing from the Global Burden of Diseases, Injuries, and Risk Factors Study 2017 (GBD 2017) LRI estimates. Methods: We used four strategies to model LRI burden: the mortality due to LRIs was modelled using vital registration data, demographic surveillance data, and verbal autopsy data in a predictive ensemble modelling tool; the incidence of LRIs was modelled using population representative surveys, health-care utilisation data, and scientific literature in a compartmental meta-regression tool; the attribution of risk factors for LRI mortality was modelled in a counterfactual framework; and trends in LRI mortality were analysed applying changes in exposure to risk factors over time. In GBD, infectious disease mortality, including that due to LRI, is among HIV-negative individuals. We categorised locations based on their burden in 1990 to make comparisons in the changing burden between 1990 and 2017 and evaluate the relative percent change in mortality rate, incidence, and risk factor exposure to explain differences in the health loss associated with LRIs among children younger than 5 years. Findings: In 2017, LRIs caused 808 920 deaths (95% uncertainty interval 747 286–873 591) in children younger than 5 years. Since 1990, there has been a substantial decrease in the number of deaths (from 2 337 538 to 808 920 deaths; 65·4% decrease, 61·5–68·5) and in mortality rate (from 362·7 deaths [330·1–392·0] per 100 000 children to 118·9 deaths [109·8–128·3] per 100 000 children; 67·2% decrease, 63·5–70·1). LRI incidence declined globally (32·4% decrease, 27·2–37·5). The percent change in under-5 mortality rate and incidence has varied across locations. Among the risk factors assessed in this study, those responsible for the greatest decrease in under-5 LRI mortality between 1990 and 2017 were increased coverage of vaccination against Haemophilus influenza type b (11·4% decrease, 0·0–24·5), increased pneumococcal vaccine coverage (6·3% decrease, 6·1–6·3), and reductions in household air pollution (8·4%, 6·8–9·2). Interpretation: Our findings show that there have been substantial but uneven declines in LRI mortality among countries between 1990 and 2017. Although improvements in indicators of sociodemographic development could explain some of these trends, changes in exposure to modifiable risk factors are related to the rates of decline in LRI mortality. No single intervention would universally accelerate reductions in health loss associated with LRIs in all settings, but emphasising the most dominant risk factors, particularly in countries with high case fatality, can contribute to the reduction of preventable deaths. Funding: Bill & Melinda Gates Foundation.
Start page
60
End page
79
Volume
20
Issue
1
Language
English
OCDE Knowledge area
Pediatría
Enfermedades infecciosas
Scopus EID
2-s2.0-85076678739
PubMed ID
Source
The Lancet Infectious Diseases
ISSN of the container
14733099
Sponsor(s)
Research reported in this publication was supported by the Bill & Melinda Gates Foundation. AA acknowledges support by the Department of Science and Technology, Government of India (New Delhi, India) through the INSPIRE Faculty program. SA acknowledges the International Centre for Casemix and Clinical Coding, the Faculty of Medicine, National University of Malaysia, and the Department of Health Policy and Management, Faculty of Public Health, Kuwait University for the approval and support to participate in this research project. ABad acknowledges support from the Public Health Agency of Canada. ABar acknowledges support for research from the Project of Ministry of Education, Science and Technology of the Republic of Serbia ( number III45005 ). FC acknowledges funding support from Foundation for Science and Technology/Minister of Science, Technology, and Higher Education through national funds ( UID/MULTI/04378/2019 and UID/QUI/50006/2019 ). AJC acknowledges support by the Health Effects Institute, Boston, MA, USA. MMSM acknowledges the support from the Ministry of Education, Science and Technological Development, Republic of Serbia ( Contract number 175087 ). AMS was supported by the Egyptian Fulbright Mission Program (EFMP). RS-S acknowledges support from Applied and Environmental Sciences University (Bogota, Colombia). AS acknowledges support from Health Data Research UK.
Sources of information:
Directorio de Producción Científica
Scopus